Health Care/Hospital News & Press Release Distribution

SYNTEC Group Recognized for Employee Health and Community Well-Being at Asia Responsible Enterprise Awards 2026

KUALA LUMPUR, Malaysia, Aug. 6, 2026 /PRNewswire/ -- SYNTEC Group has been recognized at the Asia Responsible Enterprise Awards (AREA) 2026, organized by Enterprise Asia, under the Health Promotion category for its "Employee Health Support System", which promotes employee well-being, psychologica...

2026-08-06 09:00 4428

From Patient to Storyteller: Dale Returns to Shanghai After CAR-T Recovery, Sharing a Journey of Hope

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- After overcoming stage 4B lymphoma through CAR-T therapy, New Zealand patient Dale has returned to Shanghai—not as a patient seeking treatment, but as a survivor sharing his story. Recently, Dale came back to the city where he received life-changing care, to...

2026-08-06 08:57 2085

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2026-08-06 08:00 4549

Telix to Host R&D Day in New York City on September 22, 2026

MELBOURNE, Australia and INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will host a Research and Development (R&D) Day on Tuesday, September 22, 2026, from 8:30 a.m. to 12:30 p.m. EDT in New York City. Institutional...

2026-08-06 05:00 2910

NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-08-05 21:15 4566

NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

Nearly 3 in 10 Veterinarians at Japan's Larger Companion-Animal Hospitals Say Their Current Pace Is Unsustainable, Zpeer Survey Finds

TOKYO, August 5, 2026 /PRNewswire/ -- Zpeer Inc., operator of Vetpeer — Japan's largest online community for veterinary professionals, reaching approximately 80% of the country's small-animal veterinarians —today released the results of a survey of 314 companion-animal veterinarians on their work...

2026-08-05 21:00 3068

KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities

JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...

2026-08-05 20:53 3703

KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities

JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...

2026-08-05 20:30 3404

Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization

CRANBURY, N.J. and SUZHOU,China, Aug. 5, 2026 /PRNewswire/ -- Recently, Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA).This milestone qualifies Porton Advanced to undertak...

2026-08-05 20:00 2193

Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product

* Alteogen grants exclusive rights to develop and commercialize a subcutaneous biologic product using Hybrozyme™-based hyaluronidase ALT-B4 * Alteogen is eligible to receive up to US$365 million, including an upfront payment and development, regulatory and sales milestone payments * Addition...

2026-08-05 20:00 2578

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea

Advanced Capsule Technology for Improved Digestive Enzyme Delivery SEOUL, South Korea, Aug. 5, 2026 /PRNewswire/ -- Lonza Capsugel has released new peer-reviewed research showing that its Licaps® DUOCAP® capsule-in-capsule technology can significantly improve the protection and targeted deliv...

2026-08-05 18:39 3370

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea

Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim result...

2026-08-05 17:37 2490

INTCO Medical Recognized in S&P Global Sustainability Yearbook (China Edition) 2025 for ESG Progress

ZIBO, China, Aug. 5, 2026 /PRNewswire/ -- INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has been included in S&P Global's Sustainability Yearbook (China Edition) 2025 and recognized as an Industry Mover for its ESG progress, re...

2026-08-05 17:27 3026

Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026

Earnings Conference Call to be Held on August 20, 2026 HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced that it will repo...

2026-08-05 17:19 2170

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, tod...

2026-08-05 15:00 2076

Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor (CAR) T-cell therapy approved for the treatment of solid tumors, for eligible patients with Claudin18.2-posi...

2026-08-05 14:06 1559

Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR

Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisram cements its strategic leadership across APAC HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices...

2026-08-05 12:11 2550

Singapore Startup Genie Health Launches Personal Health Intelligence Platform for Consumers and Healthcare Providers

SINGAPORE, Aug. 5, 2026 /PRNewswire/ -- As people live longer and chronic conditions become increasingly common, managing health has quietly become more complex than ever before. Consumers now juggle medical reports, health screenings, wearable devices, medications and advice from multiple provid...

2026-08-05 11:05 3166

Singapore Startup Genie Health Launches Personal Health Intelligence Platform for Consumers and Healthcare Providers

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, today announced its unaudit...

2026-08-05 04:30 4805

NIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance

Now commercially available, the medium cut-off dialyzer expands access to enhanced middle molecule removal through existing dialysis infrastructure OSAKA, Japan and BRIDGEWATER, N.J., Aug. 4, 2026 /PRNewswire/ -- NIPRO CORPORATION, through its U.S.-based subsidiary Nipro Medical Corporation, toda...

2026-08-04 22:01 2721